跳至主要内容
临床试验/NCT01974700
NCT01974700终止4 期

Seizure Prophylaxis in Aneurysm Repair

Indiana University1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2013年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
入组人数
17
试验地点
1
主要终点
Incidence of Seizure

研究概览

简要总结

Seizures are a potential complication of surgical repair of intracranial aneurysms. In order to prevent seizures, many surgeons administer prophylactic anti-epileptic medication during the intra-operative and post-operative period, however, such practice is not supported by clinical data. Retrospective review found the incidence of postoperative seizures was higher in those who received anti-epileptics versus those who did not. The goal is to examine the utility of levetiracetam (Keppra) for seizure prophylaxis in patients undergoing surgical repair of unruptured intracranial aneurysms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult (≥18 years)
  • Presence of intracranial aneurysm (without rupture)
  • Treating surgeon has recommended surgical repair of the aneurysm.

排除标准

  • History of seizures within last 10 years
  • History of epilepsy
  • History of prior stroke
  • Currently prescribed medication with anti-epileptic activity (keppra,dilantin, tegretol, lamictal, topamax, etc.)
  • Brain tumor
  • Pregnant or nursing woman
  • Known levetiracetam allergy

研究组 & 干预措施

Levetiracetam

Active Comparator

干预措施: Levetiracetam (Drug)

结局指标

主要结局

Incidence of Seizure

时间窗: 6 mo - 1 Year from Operative Procedure

Reported via patient in follow-up phone call.

次要结局

  • Number of Participants Who Returned to Daily Activities.(6 months - 12 months)
  • Number of Participants Who Returned to Work(6 months - 12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Seizure Prophylaxis in Aneurysm Repair | 临床试验